Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adrenocortical Carcinoma × Sunitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 73 Neoplasm Metastasis 30 Kidney Neoplasms 26 Neoplasms 19 Breast Neoplasms 14 Prostatic Neoplasms 12 Urinary Bladder Neoplasms 10 Melanoma 9 Gastrointestinal Stromal Tumors 9 Brain Neoplasms 9 Glioblastoma 8 Sarcoma 7 Carcinoma, Non-Small-Cell Lung 7 Liver Neoplasms 6 Carcinoma, Hepatocellular 6 Recurrence 5 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Esophageal Neoplasms 5 Colorectal Neoplasms 5 Thyroid Neoplasms 4 Solid Tumors 4 Osteosarcoma 4 Lung Neoplasms 4 Leukemia, Myeloid, Acute 4 Adenocarcinoma 4 Uveal Melanoma 3 Thymoma 3 Stomach Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Mitotane 7 Cisplatin 6 pembrolizumab 5 Etoposide 3 Doxorubicin 3 camrelizumab 2 apatinib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Cytoreduction Surgical Procedures 2 sodium thiosulfate 1 iodophenyl metomidate 1 fludarabine phosphate 1 dostarlimab 1 cemiplimab 1 cabozantinib 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Suramin 1 Sunitinib 1 Streptozocin 1 Sorafenib 1 Radiation 1 Paclitaxel 1 Observation 1 Nivolumab 1 Megestrol Acetate 1 Lymph Node Excision 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00453895 2019-01-31

SIRAC

University of Wuerzburg

Phase 2 Completed

39 enrolled 10 charts

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡